Table 1.

Baseline

	Total (n = 4386)	non-PC-AKI (n = 3599)	PC-AKI (n = 787)	P
Male, n/%	2895/66	2422/67.3	473/60.1	<0.001
Age, years	68/13	68/13	70/13	<0.001
Smoking, n/%	744/17	628/17.4	116/14.7	0.067
Drinking, n/%	674/15.4	576/16	98/12.5	0.012
Hypertension, n/%	2788/63.6	2274/63.2	514/65.3	0.261
Diabetes, n/%	1058/24.1	836/23.2	222/28.2	0.003
eGFR, mL/min/1.73 m2	84.38/28.9	84.61/27.41	83.02/38.1	0.012
Uric acid, μmol/L	364/135	364/131	364/150	0.504
LDL-C, mmol/L	2.08/1.13	2.08/1.12	2.08/1.18	0.485
CRP, mg/L	2.3/7.13	2/5.8	4.4/14.8	<0.001
LVEF, %	62/16	62.8/14.53	59.5/17.9	<0.001
Pre-operative statin therapy, n/%	3654/83.3	3051/84.8	603/76.6	<0.001
Atorvastatin, n/%	2307/63.1	1906/62.5	401/66.5	0.173
ACEI, n/%	704/16.1	565/15.7	139/17.7	0.174
Diuretic, n/%	1383/31.5	1124/31.2	259/32.9	0.359
Aspirin, n/%	3632/82.8	2969/82.5	663/84.2	0.206
Ezetimibe, n/%	275/6.3	237/6.6	38/4.8	0.066
Excess volumes of CM, n/%	185/4.6	137/4.2	48/6.6	0.005
Iso-osmolar CM, n/%	1380/31.6	1132/31.6	248/31.6	0.988
Contrast Volume, ml	80/80	80/80	80/90	0.249
Prior myocardial infarction, n/%	71/1.6	58/1.6	13/1.7	0.935
Prior PCI, n/%	230/5.2	191/5.3	May-39	0.689
Prior CABG, n/%	15/0.3	14/0.4	1/0.1	0.254
Prior cardiac surgery /except CABG, n/%	15/0.3	11/0.3	4/0.5	0.378
Angiography combined with PCI, n/%	1925/43.9	1571/43.7	354/45	0.496
Multi vessel PCI, n/%	1075/56.2	878/56.2	197/56.1	0.977
Total length of stents, mm	38/38	39/39	36/33.5	0.083

Abbreviations: PC-AKI post-contrast acute kidney injury, eGFR estimated glomerular filtration rate, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, LVEF left ventricular ejection fractions, CM contrast medium, ACEI angiotensin converting enzyme inhibitors, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting